{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:29:00Z","timestamp":1774729740912,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.transci.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T12:49:02Z","timestamp":1532868542000},"page":"463-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Current approaches to diagnostic testing in von Willebrand Disease"],"prefix":"10.1016","volume":"57","author":[{"given":"Emily Southard","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.transci.2018.07.005_bib0005","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s Disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transci.2018.07.005_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"22","key":"10.1016\/j.transci.2018.07.005_bib0015","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2017-05-782029","article-title":"Advances in the diagnosis and treatment of Von Willebrand disease","volume":"130","author":"Sharma","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.transci.2018.07.005_bib0020","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.transci.2018.07.005_bib0025","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre doctors organization guideline approved by the British Committee for standards in haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.transci.2018.07.005_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ijlh.12761","article-title":"Bleeding score in type 1 von Willebrand disease patients using the ISTH-BAT questionnaire","volume":"40","author":"Pathare","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"10.1016\/j.transci.2018.07.005_bib0035","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny","year":"2014","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.transci.2018.07.005_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26588","article-title":"Generation and optimization of the self-administered pediatric bleeding questionnaire and its validation as a screening tool for von Willebrand disease","volume":"64","author":"Casey","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.transci.2018.07.005_bib0045","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/hae.12747","article-title":"Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease","volume":"21","author":"Deforest","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.transci.2018.07.005_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12959-016-0123-z","article-title":"Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories","volume":"14","author":"Magnette","year":"2016","journal-title":"Thromb J"},{"issue":"Suppl 3","key":"10.1016\/j.transci.2018.07.005_bib0055","doi-asserted-by":"crossref","first-page":"iii18","DOI":"10.1093\/bja\/aew358","article-title":"Perioperative management of the bleeding patient","volume":"117","author":"Ghadimi","year":"2016","journal-title":"Br J Anaesth"},{"issue":"20","key":"10.1016\/j.transci.2018.07.005_bib0060","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2018.07.005_bib0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2014-11-613935","article-title":"Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease","volume":"126","author":"Chen","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.transci.2018.07.005_bib0070","doi-asserted-by":"crossref","first-page":"e60396","DOI":"10.1371\/journal.pone.0060396","article-title":"Prevalence of disease and relationships between laboratory phenotype and bleeding severity in platelet primary secretion defects","volume":"8","author":"Lotta","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jth.13883","article-title":"The ISTH bleeding assessment tool and the risk of future bleeding","volume":"16","author":"Fasulo","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-2257.2000.00281.x","article-title":"Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer","volume":"22","author":"Sukhu","year":"2000","journal-title":"Clin Lab Haematol"},{"issue":"8","key":"10.1016\/j.transci.2018.07.005_bib0085","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00001721-200012000-00006","article-title":"Assessment of current diagnostic practice and efficacy in testing for von Willebrand\u2019s disorder: results from the second Australasian multi-laboratory survey","volume":"11","author":"Favaloro","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"11","key":"10.1016\/j.transci.2018.07.005_bib0090","first-page":"1180","article-title":"Evaluation of an automated method for the quantification of von Willebrand factor antigen. Its application in the study of vascular dysfunction","volume":"86","author":"Villa","year":"2001","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1096-8652(200101)66:1<53::AID-AJH1009>3.0.CO;2-I","article-title":"Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor","volume":"66","author":"Favaloro","year":"2001","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.transci.2018.07.005_bib0100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.transci.2018.07.005_bib0105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12064","article-title":"A comparative evaluation of a new automated assay for von Willebrand factor activity","volume":"19","author":"Lawrie","year":"2013","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.transci.2018.07.005_bib0110","first-page":"178","article-title":"Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification","volume":"21","author":"Favaloro","year":"2008","journal-title":"Clin Lab Sci"},{"issue":"6","key":"10.1016\/j.transci.2018.07.005_bib0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.transci.2018.07.005_bib0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2018.07.005_bib0125","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.transci.2018.07.005_bib0130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bodo","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.transci.2018.07.005_bib0135","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","article-title":"Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and innovance","volume":"112","author":"de Maistre","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.transci.2018.07.005_bib0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.transci.2018.07.005_bib0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.12019","article-title":"Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity","volume":"35","author":"Ni","year":"2013","journal-title":"Int J Lab Hematol"},{"issue":"10","key":"10.1016\/j.transci.2018.07.005_bib0150","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1373\/clinchem.2006.070730","article-title":"Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease","volume":"52","author":"Popov","year":"2006","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0155","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/asheducation-2014.1.531","article-title":"New insights into genotype and phenotype of VWD","volume":"2014","author":"Flood","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Progr."},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105.","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2018.07.005_bib0170","first-page":"630","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.transci.2018.07.005_bib0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.blre.2016.08.003","article-title":"Genetic diagnosis in hemophilia and von Willebrand disease","volume":"31","author":"Swystun","year":"2017","journal-title":"Blood Rev"},{"issue":"19","key":"10.1016\/j.transci.2018.07.005_bib0180","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.transci.2018.07.005_bib0185","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2018.07.005_bib0190","doi-asserted-by":"crossref","first-page":"e0188405","DOI":"10.1371\/journal.pone.0188405","article-title":"A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct","volume":"12","author":"Lynch","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.transci.2018.07.005_bib0195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-0028-1103361","article-title":"The role of molecular genetics in diagnosing von Willebrand disease","volume":"34","author":"James","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.transci.2018.07.005_bib0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/GIM.0b013e3182035931","article-title":"von Willebrand disease","volume":"13","author":"James","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.transci.2018.07.005_bib0205","series-title":"von Willebrand Disease, in GeneReviews ((R))","author":"Goodeve","year":"1993"},{"issue":"5","key":"10.1016\/j.transci.2018.07.005_bib0210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.transci.2018.07.005_bib0215","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2018.07.005_bib0220","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletions correlate with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton-Inloes","year":"1987","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.transci.2018.07.005_bib0225","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218302830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218302830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T12:30:24Z","timestamp":1571661024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050218302830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1473050218302830"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2018.07.005","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current approaches to diagnostic testing in von Willebrand Disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}